FdaApplication
ANDA 202718
Identifiers
- fda_app_no: ANDA202718
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA |
| application_type | ANDA |
| approval_date | 2014-12-29 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MORPHINE SULFATE | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 70MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 20MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 40MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MORPHINE SULFATE | MORPHINE SULFATE | 80MG | CAPSULE, EXTENDED RELEASE;ORAL |
8 products